In June 2009, a technical consultation held at the World Health Organization (WHO) in Geneva concluded that evidence supports the introduction, continuation, and scale-up of community-based provision of progestin-only injectable contraceptives. The group of 30 technical and programme experts reviewed scientific and programmatic experience, which largely focused on the progestin-only injectable, depot-medroxyprogesterone acetate (DMPA). The experts found that community-based provision of progestin-only injectable contraceptives by appropriately trained community health workers (CHWs) is safe, effective, and acceptable. Such services should be part of a family planning programme offering a range of contraceptive methods.

In June 2010, seven new international organizations endorsed the policy brief. The International Confederation of Midwives, International Council of Nurses, and International Federation of Gynecology and Obstetrics (FIGO) — the three medical professional associations related to this topic — endorsed this brief. Also, key international organizations supporting family planning services added their endorsement: International Planned Parenthood Federation, Marie Stopes International, UNFPA, and the World Bank.